7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Lymphangioleiomyomatosis D018192 1 associated lipids
Bone Cysts, Aneurysmal D017824 2 associated lipids
Diabetic Foot D017719 1 associated lipids
Periodontal Attachment Loss D017622 7 associated lipids
Microvascular Angina D017566 2 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Myocardial Ischemia D017202 11 associated lipids
beta-Thalassemia D017086 5 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Carotid Stenosis D016893 15 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Çankaya M et al. The effects of chronic zoledronate usage on the jaw and long bones evaluated using RANKL and osteoprotegerin levels in an animal model. 2013 Int J Oral Maxillofac Surg pmid:23522850
Pichler K et al. RANKL is downregulated in bone cells by physical activity (treadmill and vibration stimulation training) in rat with glucocorticoid-induced osteoporosis. 2013 Histol. Histopathol. pmid:23553492
Fuernau G et al. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging. 2013 Int. J. Cardiol. pmid:22704876
Weiss RM et al. Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice. 2013 PLoS ONE pmid:23762316
Ding Q and Zhang FQ [Effect of icariin on the expression of receptor activator nuclear factor-κB ligand and osteoprotegerin of human periodontal ligament cells]. 2013 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:23714056
Okamura H et al. Protein phosphatase 2A Cα is involved in osteoclastogenesis by regulating RANKL and OPG expression in osteoblasts. 2013 FEBS Lett. pmid:23183242
Tecilazich F et al. Postexercise phosphocreatine recovery, an index of mitochondrial oxidative phosphorylation, is reduced in diabetic patients with lower extremity complications. 2013 J. Vasc. Surg. pmid:23465172
Loiselle AE et al. Inhibition of GSK-3β rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice. 2013 PLoS ONE pmid:24260576
Ye Z et al. Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease. 2013 Am. J. Hypertens. pmid:23467205
Fekete S et al. The effect of levetiracetam on rat bone mass, structure and metabolism. 2013 Epilepsy Res. pmid:24035343
He T et al. Multiple biomarkers analysis for the early detection of prosthetic aseptic loosening of hip arthroplasty. 2013 Int Orthop pmid:23467893
Lin C et al. The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells. 2013 PLoS ONE pmid:23469146
Kovács G et al. [Metabolic differences in healthy first-degree female relatives of type 2 diabetic patients]. 2013 Orv Hetil pmid:24161599
Jiang W et al. Identification of five serum protein markers for detection of ovarian cancer by antibody arrays. 2013 PLoS ONE pmid:24116163
Riesco M et al. Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures. 2013 Clin. Rheumatol. pmid:23846386
Canalis E et al. Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling. 2013 J. Biol. Chem. pmid:23884415
Szymczak J and Bohdanowicz-Pawlak A Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate. 2013 Horm. Metab. Res. pmid:23888411
Xi L et al. OPG/RANK/RANKL axis in stabilization of spontaneously restored sinus rhythm in permanent atrial fibrillation patients after mitral valve surgery. 2013 Cardiology pmid:23295350
Steinmetz M et al. Atorvastatin-induced increase in progenitor cell levels is rather caused by enhanced receptor activator of NF-kappaB ligand (RANKL) cell proliferation than by bone marrow mobilization. 2013 J. Mol. Cell. Cardiol. pmid:23295770
Eleftheriadis T et al. Serum osteoprotegerin is markedly increased and may contribute to decreased blood T cell count in hemodialysis patients. 2013 Int Urol Nephrol pmid:23296793
dos Santos PL et al. Guided implant surgery: what is the influence of this new technique on bone cell viability? 2013 J. Oral Maxillofac. Surg. pmid:23298799
Jimi E et al. The RANKL/RANK system as a therapeutic target for bone invasion by oral squamous cell carcinoma (Review). 2013 Int. J. Oncol. pmid:23354319
Kebschull M et al. Mobilization of endothelial progenitors by recurrent bacteremias with a periodontal pathogen. 2013 PLoS ONE pmid:23355901
Velusamy SK et al. Lactoferrin knockout mice demonstrates greater susceptibility to Aggregatibacter actinomycetemcomitans-induced periodontal disease. 2013 J. Periodontol. pmid:23327622
Olivares-Navarrete R et al. Rough titanium alloys regulate osteoblast production of angiogenic factors. 2013 Spine J pmid:23684238
Milone F et al. Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases. 2013 Biomarkers pmid:23336103
Zhang ZG et al. Therapeutic effect of aqueous extract from Ecliptae herba on bone metabolism of ovariectomized rats. 2013 Menopause pmid:23096243
Giganti MG et al. Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. 2012 Oct-Dec J. Biol. Regul. Homeost. Agents pmid:23241117
Heitzer E et al. IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. 2012 Nov-Dec Pain Physician pmid:23159968
Nuño-Arana I et al. Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. 2012 Jul-Aug Am. J. Hum. Biol. pmid:22434650
Varsavsky M et al. Serum osteoprotegerin and sex steroid levels in patients with prostate cancer. 2012 Jul-Aug J. Androl. pmid:21903971
Dalezis P et al. Dexamethasone plus octreotide regimen increases anticancer effects of docetaxel on TRAMP-C1 prostate cancer model. 2012 Jan-Feb In Vivo pmid:22210719
Ambroszkiewicz J et al. [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]. 2012 Apr-Jun Med Wieku Rozwoj pmid:22971655
Wang Y et al. Curculigoside isolated from Curculigo orchioides prevents hydrogen peroxide-induced dysfunction and oxidative damage in calvarial osteoblasts. 2012 Acta Biochim. Biophys. Sin. (Shanghai) pmid:22427460
Koch FP et al. Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro. 2012 Clin Oral Investig pmid:20938793
Liang D et al. Zinc upregulates the expression of osteoprotegerin in mouse osteoblasts MC3T3-E1 through PKC/MAPK pathways. 2012 Biol Trace Elem Res pmid:22081405
García-Hernández A et al. High glucose concentrations alter the biomineralization process in human osteoblastic cells. 2012 Bone pmid:22086137
Kühn MC et al. Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation. 2012 Mol. Cell. Endocrinol. pmid:22040599
Janda K et al. [The relationship between advancement of secondary hyperparathyroidism and selected calcification parameters in peritoneal dialysis patients]. 2012 Prz. Lek. pmid:23750431
Pineda B et al. Effects of administration of hormone therapy or raloxifene on the immune system and on biochemical markers of bone remodeling. 2012 Menopause pmid:22067277
Roodman GD Genes associate with abnormal bone cell activity in bone metastasis. 2012 Cancer Metastasis Rev. pmid:22706844
Chuang FH et al. Long-term sequential receptor activator of NF-κB ligand (RANKL) and osteoprotegrin (OPG) expression in lipopolysaccharide-induced rat periapical lesions. 2012 J. Oral Pathol. Med. pmid:21793936
Rodriguez-Lorenzo LM et al. Feasibility of ceramic-polymer composite cryogels as scaffolds for bone tissue engineering. 2012 J Tissue Eng Regen Med pmid:21800433
Martínez-Calatrava MJ et al. RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis. 2012 Arthritis Res. Ther. pmid:22709525
Kim H et al. The association between polymorphisms in Wnt antagonist genes and bone response to hormone therapy in postmenopausal Korean women. 2012 Menopause pmid:22668815
Marzaioli V et al. Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes. 2012 Arthritis Rheum. pmid:22674155
Tanaka M et al. Effect of Reveromycin A on experimental tooth movement in OPG-/- mice. 2012 J. Dent. Res. pmid:22674934
Yan J et al. Bone marrow ablation demonstrates that excess endogenous parathyroid hormone plays distinct roles in trabecular and cortical bone. 2012 Am. J. Pathol. pmid:22640808
Kim S et al. Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis. 2012 Diagn. Microbiol. Infect. Dis. pmid:22647538
Kanbe K et al. Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis. 2012 Rheumatol. Int. pmid:21789615
Nonaka CF et al. Immunohistochemical analysis of bone resorption regulators (RANKL and OPG), angiogenic index, and myofibroblasts in syndrome and non-syndrome odontogenic keratocysts. 2012 Arch. Oral Biol. pmid:21871606
Yoon HY et al. Poncirin prevents bone loss in glucocorticoid-induced osteoporosis in vivo and in vitro. 2012 J. Bone Miner. Metab. pmid:22407507
Wen Y et al. Application of eGFP to label human periodontal ligament stem cells in periodontal tissue engineering. 2012 Arch. Oral Biol. pmid:22410147
Vasconcelos AC et al. Comparison of effects of clodronate and zoledronic acid on the repair of maxilla surgical wounds - histomorphometric, receptor activator of nuclear factor-kB ligand, osteoprotegerin, von Willebrand factor, and caspase-3 evaluation. 2012 J. Oral Pathol. Med. pmid:22417074
Hwang JJ et al. Receptor activator of nuclear factor-κB ligand (RANKL) and its relationship to coronary atherosclerosis in HIV patients. 2012 J. Acquir. Immune Defic. Syndr. pmid:22842843
Dorota DK et al. The concentrations of markers of bone turnover in normal pregnancy and preeclampsia. 2012 Hypertens Pregnancy pmid:20822429
Li YF et al. The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats. 2012 Osteoporos Int pmid:21892678
Galli C et al. Actin cytoskeleton controls activation of Wnt/β-catenin signaling in mesenchymal cells on implant surfaces with different topographies. 2012 Acta Biomater pmid:22564787
Morena M et al. Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients. 2012 PLoS ONE pmid:22567137
Banfi G et al. Osteoprotegerin, RANK and RANKL are not modified by acute exercise in elite rugby players. 2012 J Sports Med Phys Fitness pmid:22525657
Wilkison M et al. Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection. 2012 Am. J. Pathol. pmid:22626807
Wang QP et al. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand. 2012 Bone pmid:22634178
Brunetti G et al. Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene. 2012 Endocrine pmid:22638612
Dougall WC Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. 2012 Clin. Cancer Res. pmid:22031096
Tibullo D et al. Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors. 2012 Hematol Oncol pmid:21544849
Li YQ et al. Dose-dependent effects of genistein on bone homeostasis in rats' mandibular subchondral bone. 2012 Acta Pharmacol. Sin. pmid:22120966
Babür C et al. Gingival crevicular fluid levels of osteoprotegerin (OPG) in premenopausal and postmenopausal women with or without chronic periodontitis. 2012 J Dent pmid:22326720
Bataille C et al. Different sympathetic pathways control the metabolism of distinct bone envelopes. 2012 Bone pmid:22326888
Taylor RM et al. CD14- mononuclear stromal cells support (CD14+) monocyte-osteoclast differentiation in aneurysmal bone cyst. 2012 Lab. Invest. pmid:22330339
Wei W et al. Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22315431
Chen YH et al. Relationship between bone mineral density and serum osteoprotegerin in patients with chronic heart failure. 2012 PLoS ONE pmid:22957004
Feng G et al. Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women. 2012 J. Pediatr. Endocrinol. Metab. pmid:23329761
Hogrefe C et al. Single impact cartilage trauma and TNF-α: interactive effects do not increase early cell death and indicate the need for bi-/multidirectional therapeutic approaches. 2012 Int. J. Mol. Med. pmid:22922824
Pereda GO et al. Inflammatory and bone regulators expression in murine macrophages under exposure of commercial and experimental mineral trioxide aggregate. 2012 Aust Dent J pmid:22924350
Tyagi AM et al. Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. 2012 PLoS ONE pmid:22970248
Kadoglou NP et al. Arterial stiffness and novel biomarkers in patients with abdominal aortic aneurysms. 2012 Regul. Pept. pmid:22982141
Yilmaz Y and Eren F Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis. 2012 Clin. Chim. Acta pmid:22985537
Nicu EA et al. RCT comparing implants with turned and anodically oxidized surfaces: a pilot study, a 3-year follow-up. 2012 J. Clin. Periodontol. pmid:23151294
Ahmed HH et al. Potential role of leptin against glucocorticoid-induced secondary osteoporosis in adult female rats. 2012 Eur Rev Med Pharmacol Sci pmid:23104664
Zhou YB et al. Insulin resistance induces medial artery calcification in fructose-fed rats. 2012 Exp. Biol. Med. (Maywood) pmid:22238287
Kwon SR et al. Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy. 2012 Rheumatol. Int. pmid:21833531
Jia P et al. [The effect of ferric ion on the differentiation of osteoclast and bone resorption]. 2012 Zhonghua Yi Xue Za Zhi pmid:23158430
Jacot W et al. Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy. 2012 Breast Cancer Res. Treat. pmid:22562178
Dieset I et al. Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein. 2012 Schizophr. Res. pmid:22817875
Upton AR et al. The expression of RANKL and OPG in the various grades of osteoarthritic cartilage. 2012 Rheumatol. Int. pmid:21259010
Wang F et al. Icariin enhances the healing of rapid palatal expansion induced root resorption in rats. 2012 Phytomedicine pmid:22818561
Chen B et al. Canonical Wnt signaling is required for Panax notoginseng saponin-mediated attenuation of the RANKL/OPG ratio in bone marrow stromal cells during osteogenic differentiation. 2012 Phytomedicine pmid:22818895
Crotti TN et al. The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints. 2012 Arthritis Res. Ther. pmid:23146195
Rieder P et al. TiNOx coatings increase human primary osteoblasts proliferation independently of the substrate: a short report. 2012 Biomed Mater Eng pmid:23023144
Jansson AM et al. Multimarker risk assessment including osteoprotegerin and CXCL16 in acute coronary syndromes. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:23023373
Taylan A et al. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis. 2012 BMC Musculoskelet Disord pmid:23025387
Shen C et al. Relation between bone mineral density, bone loss and the risk of cardiovascular disease in a Chinese cohort. 2012 Am. J. Cardiol. pmid:22762713
Dey P et al. Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3. 2012 Mol. Endocrinol. pmid:23028063
Luan X et al. Crystal structure of human RANKL complexed with its decoy receptor osteoprotegerin. 2012 J. Immunol. pmid:22664871
Song TJ et al. Association of plasma osteoprotegerin levels with stroke severity and functional outcome in acute ischaemic stroke patients. 2012 Biomarkers pmid:23030274
Galli C et al. Effect of surface treatment on cell responses to grades 4 and 5 titanium for orthodontic mini-implants. 2012 Am J Orthod Dentofacial Orthop pmid:22640672
Ostrowska Z et al.  Dehydroepiandrosterone sulfate, osteoprotegerin and its soluble ligand sRANKL and bone metabolism in girls with anorexia nervosa. 2012 Postepy Hig Med Dosw (Online) pmid:23001207
Belibasakis GN and Bostanci N The RANKL-OPG system in clinical periodontology. 2012 J. Clin. Periodontol. pmid:22092994
Ramirez-Yanez GO and Symons AL Prostaglandin E2 affects osteoblast biology in a dose-dependent manner: an in vitro study. 2012 Arch. Oral Biol. pmid:22480456
Dalbeth N and McQueen FM Clarification of the modified radiographic damage scoring method for gout. 2012 J. Rheumatol. pmid:22467953

Table of Content